StockMarketWire.com - OptiBiotix Health said it had boosted its annual income as it continued to transition from an R&D business to a commercial company generating sales.

Revenue for the year through November had jumped to £541k, up from £191k on-year, with the bulk booked in the second half of the year.

'We anticipate further revenue growth in 2019 as existing deals contribute to full year revenues, and partners continue to grow sales,' the company said.




Story provided by StockMarketWire.com